Takeda Pharmaceutical Company Limited American Depositary Shares (each (NY:TAK)
All News about Takeda Pharmaceutical Company Limited American Depositary Shares (each
HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda
September 24, 2024
Via GlobeNewswire
Via PressReach
Takeda Announces New Assignments of Directors
June 26, 2024
Via Business Wire